SCHEMBL7670384

SCHEMBL7670384

C[S+]([O-])c1c(C(N)=S)nn(-c2c(Cl)cc(OC(F)(F)F)cc2Cl)c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 18/20 0.36
GABRD O14764 18/20 0.36
GABRA1 P14867 18/20 0.36
GABRB1 P18505 18/20 0.36
GABRG2 P18507 18/20 0.36
GABRB3 P28472 18/20 0.36
GABRA5 P31644 18/20 0.36
GABRA3 P34903 18/20 0.36
GABRA2 P47869 18/20 0.36
GABRB2 P47870 18/20 0.36
GABRA4 P48169 18/20 0.36
GABRE P78334 18/20 0.36
GABRA6 Q16445 18/20 0.36
GABRG1 Q8N1C3 18/20 0.36
GABRG3 Q99928 18/20 0.36
GABRQ Q9UN88 18/20 0.36
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7242692 0.89 GABRP (0.34) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7667667 0.89 GABRP (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7242687 0.85 GABRP (0.36) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7667746 0.85 GABRP (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7670386 0.82 GABRP (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7024338 0.80 GABRP (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7024260 0.80 GABRP (0.34) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7024263 0.80 GABRP (0.34) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7673514 0.79 GABRP (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL677097 0.76 GABRP (0.41) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020016468-A1 PESTICIDAL 1-ARYLPYRAZOLE DERIVATIVES RHONE-POULENC AGROCHIMIE (FR) 2002-02-07 US claimed
US-20020016468-A1 PESTICIDAL 1-ARYLPYRAZOLE DERIVATIVES RHONE-POULENC AGROCHIMIE (FR) 2002-02-07 US disclosed
EP-0948487-A1 PESTICIDAL 1-ARYL AND PYRIDYLPYRAZOLE DERIVATIVES RHONE-POULENC AGROCHIMIE (FR) 1999-10-13 EP disclosed
WO-1998028279-A1 PESTICIDAL 1-ARYL AND PYRIDYLPYRAZOLE DERIVATIVES RHONE-POULENC AGROCHIMIE (FR) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016468-A1 PESTICIDAL 1-ARYLPYRAZOLE DERIVATIVES DDT, NAT1, CYP2E1 GABRP 1003/4885GABRD 1930/4885GABRA1 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.